Blanck, Oliver
Buergy, Daniel
Vens, Maren
Eidinger, Lina
Zaman, Adrian
Krug, David
Rudic, Boris
Boda-Heggemann, Judit
Giordano, Frank A.
Boldt, Leif-Hendrik
Mehrhof, Felix
Budach, Volker
Schweikard, Achim
Olbrich, Denise
König, Inke R.
Siebert, Frank-Andre
Vonthein, Reinhard
Dunst, Jürgen
Bonnemeier, Hendrik
Article History
Received: 20 November 2019
Accepted: 8 April 2020
First Online: 18 April 2020
Compliance with ethical standards
:
: OB reports to have been an employee of CyberHeart Inc. (Sunnyvale, CA, USA) from 2008 to 2010 during the initial preclinical studies for cardiac radiosurgery, though he reports no financial ties or obligations or conflict of interest to or with the company or its legal predecessor Varian Inc. (Sunnyvale, CA, USA). DB reports personal fees from Siemens AG, personal fees from NB Capital Research GmbH, personal fees from NB Capital ApS, personal fees from b.e. Imaging GmbH, outside the submitted work. DK has received honoraria from Merck Sharp & Dome, outside of the submitted work. BR received travel grants and personal fees from Boston Scientific Medizintechnik GmbH, outside of the submitted work. All other authors report no competing interests.
: The study was approved by the German Radiation Protection Agency (Bundesamt für Strahlenschutz, reference number Z5-22463/2-2018-054) and by the lead independent ethics committee of the University of Kiel (reference number 555/18).